GASSER, RODOLFO,HERNANDEZ, MARIA-CLEMENCIA,THOMAS, ANDREW
申请号:
SG2013024831
公开号:
SG189248A1
申请日:
2011.11.01
申请国别(地区):
SG
年份:
2013
代理人:
摘要:
The present invention relates to the pharmaceutical use of selective GABA A α5 negative allosteric modulators for the treatment, prevention and/or delay of progression of central nervous system (CNS) conditions related to excessive GABAergic inhibition in the brain.